Study of 21,561 individuals reveals distinct gut microbiome patterns between vegans, vegetarians, and omnivores, with vegan-associated microbes linked to better cardiometabolic health markers.
Researchers analyzed glucagon-like peptide-1 receptor agonist discontinuation and reinitiation trends. They found higher discontinuation rates among patients without type 2 diabetes and identified weight loss, adverse events, and cost as associated factors.
FDA approves aztreonam-avibactam, the first monobactam/β-lactamase inhibitor combination antibiotic, for treating complicated intra-abdominal infections in adults with limited treatment options.
"A diagnosis of AGS should be strongly considered in patients with a history of tick bites and clinical presentation of allergic or GI manifestations."
Conexiant
Daily News
Stay up to date with the latest clinical headlines and other information tailored to your specialty.
Thank you for signing up for the Daily News alerts. You will begin receiving them shortly.
Researchers evaluated the safety, efficacy, and glycemic benefits of vonoprazan-amoxicillin dual therapy for H. pylori eradication in type 2 diabetes patients.
Large-scale study of 1.9M veterans identifies previously unreported benefits and risks of GLP-1 receptor agonists across 175 health outcomes, including reduced substance use disorders and increased pancreatitis risk.